Home > Research > Publications & Outputs > The need for reporting guidelines for early pha...

Research

Electronic data

Links

Text available via DOI:

Keywords

View graph of relations

The need for reporting guidelines for early phase dose-finding trials: Dose-Finding CONSORT Extension

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Published

Standard

The need for reporting guidelines for early phase dose-finding trials: Dose-Finding CONSORT Extension. / Yap, C.; Bedding, A.; de Bono, J. et al.
In: Nature Medicine, Vol. 28, No. 1, 31.01.2022, p. 6-7.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Harvard

Yap, C, Bedding, A, de Bono, J, Dimairo, M, Espinasse, A, Evans, J, Hopewell, S, Jaki, T, Kightley, A, Lee, S, Liu, R, Mander, A, Solovyeva, O & Weir, CJ 2022, 'The need for reporting guidelines for early phase dose-finding trials: Dose-Finding CONSORT Extension', Nature Medicine, vol. 28, no. 1, pp. 6-7. https://doi.org/10.1038/s41591-021-01594-1

APA

Yap, C., Bedding, A., de Bono, J., Dimairo, M., Espinasse, A., Evans, J., Hopewell, S., Jaki, T., Kightley, A., Lee, S., Liu, R., Mander, A., Solovyeva, O., & Weir, C. J. (2022). The need for reporting guidelines for early phase dose-finding trials: Dose-Finding CONSORT Extension. Nature Medicine, 28(1), 6-7. https://doi.org/10.1038/s41591-021-01594-1

Vancouver

Yap C, Bedding A, de Bono J, Dimairo M, Espinasse A, Evans J et al. The need for reporting guidelines for early phase dose-finding trials: Dose-Finding CONSORT Extension. Nature Medicine. 2022 Jan 31;28(1):6-7. Epub 2022 Jan 6. doi: 10.1038/s41591-021-01594-1

Author

Yap, C. ; Bedding, A. ; de Bono, J. et al. / The need for reporting guidelines for early phase dose-finding trials : Dose-Finding CONSORT Extension. In: Nature Medicine. 2022 ; Vol. 28, No. 1. pp. 6-7.

Bibtex

@article{8d0e639ea2754732b3f414435b83cf21,
title = "The need for reporting guidelines for early phase dose-finding trials: Dose-Finding CONSORT Extension",
keywords = "Drug development, Education, Phase I trials, Publication characteristics",
author = "C. Yap and A. Bedding and {de Bono}, J. and M. Dimairo and A. Espinasse and J. Evans and S. Hopewell and T. Jaki and A. Kightley and S. Lee and R. Liu and A. Mander and O. Solovyeva and C.J. Weir",
note = "The final publication is available at Springer via https://doi.org/10.1038/s41591-021-01594-1",
year = "2022",
month = jan,
day = "31",
doi = "10.1038/s41591-021-01594-1",
language = "English",
volume = "28",
pages = "6--7",
journal = "Nature Medicine",
issn = "1078-8956",
publisher = "Nature Publishing Group",
number = "1",

}

RIS

TY - JOUR

T1 - The need for reporting guidelines for early phase dose-finding trials

T2 - Dose-Finding CONSORT Extension

AU - Yap, C.

AU - Bedding, A.

AU - de Bono, J.

AU - Dimairo, M.

AU - Espinasse, A.

AU - Evans, J.

AU - Hopewell, S.

AU - Jaki, T.

AU - Kightley, A.

AU - Lee, S.

AU - Liu, R.

AU - Mander, A.

AU - Solovyeva, O.

AU - Weir, C.J.

N1 - The final publication is available at Springer via https://doi.org/10.1038/s41591-021-01594-1

PY - 2022/1/31

Y1 - 2022/1/31

KW - Drug development

KW - Education

KW - Phase I trials

KW - Publication characteristics

U2 - 10.1038/s41591-021-01594-1

DO - 10.1038/s41591-021-01594-1

M3 - Journal article

VL - 28

SP - 6

EP - 7

JO - Nature Medicine

JF - Nature Medicine

SN - 1078-8956

IS - 1

ER -